88 related articles for article (PubMed ID: 29536339)
41. Lactoferrin activates macrophages via TLR4-dependent and -independent signaling pathways.
Curran CS; Demick KP; Mansfield JM
Cell Immunol; 2006 Jul; 242(1):23-30. PubMed ID: 17034774
[TBL] [Abstract][Full Text] [Related]
42. Regulation of Interferon-γ receptor (IFN-γR) expression in macrophages during Mycobacterium tuberculosis infection.
Kak G; Tiwari BK; Singh Y; Natarajan K
Biomol Concepts; 2020 Apr; 11(1):76-85. PubMed ID: 32271156
[TBL] [Abstract][Full Text] [Related]
43. Triggering of Toll-like receptors modulates IFN-gamma signaling: involvement of serine 727 STAT1 phosphorylation and suppressors of cytokine signaling.
Dalpke AH; Eckerle S; Frey M; Heeg K
Eur J Immunol; 2003 Jul; 33(7):1776-87. PubMed ID: 12811837
[TBL] [Abstract][Full Text] [Related]
44. Smad2 and Smad3 are redundantly essential for the suppression of iNOS synthesis in macrophages by regulating IRF3 and STAT1 pathways.
Sugiyama Y; Kakoi K; Kimura A; Takada I; Kashiwagi I; Wakabayashi Y; Morita R; Nomura M; Yoshimura A
Int Immunol; 2012 Apr; 24(4):253-65. PubMed ID: 22331441
[TBL] [Abstract][Full Text] [Related]
45. Apoptotic cells inhibit LPS-induced cytokine and chemokine production and IFN responses in macrophages.
Tassiulas I; Park-Min KH; Hu Y; Kellerman L; Mevorach D; Ivashkiv LB
Hum Immunol; 2007 Mar; 68(3):156-64. PubMed ID: 17349870
[TBL] [Abstract][Full Text] [Related]
46. Inhibitors of TLR-4, NF-κB, and SAPK/JNK signaling reduce the toxic effect of lipopolysaccharide on RAW 264.7 cells.
Glushkova OV; Parfenyuk SB; Khrenov MO; Novoselova TV; Lunin SM; Fesenko EE; Novoselova EG
J Immunotoxicol; 2013; 10(2):133-40. PubMed ID: 22830990
[TBL] [Abstract][Full Text] [Related]
47. TPL-2-mediated activation of MAPK downstream of TLR4 signaling is coupled to arginine availability.
Mieulet V; Yan L; Choisy C; Sully K; Procter J; Kouroumalis A; Krywawych S; Pende M; Ley SC; Moinard C; Lamb RF
Sci Signal; 2010 Aug; 3(135):ra61. PubMed ID: 20716763
[TBL] [Abstract][Full Text] [Related]
48. DLK1 is a novel inflammatory inhibitor which interferes with NOTCH1 signaling in TLR-activated murine macrophages.
González MJ; Ruiz-García A; Monsalve EM; Sánchez-Prieto R; Laborda J; Díaz-Guerra MJ; Ruiz-Hidalgo MJ
Eur J Immunol; 2015 Sep; 45(9):2615-27. PubMed ID: 26115479
[TBL] [Abstract][Full Text] [Related]
49. IL-12/IFN-gamma/NO axis plays critical role in development of Th1-mediated experimental autoimmune encephalomyelitis.
Xiao BG; Ma CG; Xu LY; Link H; Lu CZ
Mol Immunol; 2008 Feb; 45(4):1191-6. PubMed ID: 17697713
[TBL] [Abstract][Full Text] [Related]
50. Mycobacterium avium-induced SOCS contributes to resistance to IFN-gamma-mediated mycobactericidal activity in human macrophages.
Vázquez N; Greenwell-Wild T; Rekka S; Orenstein JM; Wahl SM
J Leukoc Biol; 2006 Nov; 80(5):1136-44. PubMed ID: 16943387
[TBL] [Abstract][Full Text] [Related]
51. Lipopolysaccharide-Induced Acute Kidney Injury Is Dependent on an IL-18 Receptor Signaling Pathway.
Nozaki Y; Hino S; Ri J; Sakai K; Nagare Y; Kawanishi M; Niki K; Funauchi M; Matsumura I
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29261164
[TBL] [Abstract][Full Text] [Related]
52. Antioxidants suppress Th1-type immune response in vitro.
Schroecksnadel K; Fischer B; Schennach H; Weiss G; Fuchs D
Drug Metab Lett; 2007 Aug; 1(3):166-71. PubMed ID: 19356038
[TBL] [Abstract][Full Text] [Related]
53. Metabolic Alterations Contribute to Enhanced Inflammatory Cytokine Production in Irgm1-deficient Macrophages.
Schmidt EA; Fee BE; Henry SC; Nichols AG; Shinohara ML; Rathmell JC; MacIver NJ; Coers J; Ilkayeva OR; Koves TR; Taylor GA
J Biol Chem; 2017 Mar; 292(11):4651-4662. PubMed ID: 28154172
[TBL] [Abstract][Full Text] [Related]
54. The Prolactin Inducible Protein Modulates Antitumor Immune Responses and Metastasis in a Mouse Model of Triple Negative Breast Cancer.
Edechi CA; Ikeogu NM; Akaluka GN; Terceiro LEL; Machado M; Salako ES; Barazandeh AF; Kung SKP; Uzonna JE; Myal Y
Front Oncol; 2021; 11():639859. PubMed ID: 33777801
[TBL] [Abstract][Full Text] [Related]
55. Prolactin-induced protein (PIP)-characterization and role in breast cancer progression.
Urbaniak A; Jablonska K; Podhorska-Okolow M; Ugorski M; Dziegiel P
Am J Cancer Res; 2018; 8(11):2150-2164. PubMed ID: 30555735
[TBL] [Abstract][Full Text] [Related]
56. Prognostic Role of Prolactin-Induced Protein (PIP) in Breast Cancer.
Sauer N; Matkowski I; Bodalska G; Murawski M; Dzięgiel P; Calik J
Cells; 2023 Sep; 12(18):. PubMed ID: 37759471
[TBL] [Abstract][Full Text] [Related]
57. The origin and function of tumor-associated macrophages.
Liu Y; Cao X
Cell Mol Immunol; 2015 Jan; 12(1):1-4. PubMed ID: 25220733
[No Abstract] [Full Text] [Related]
58. Prolactin inducible protein in cancer, fertility and immunoregulation: structure, function and its clinical implications.
Hassan MI; Waheed A; Yadav S; Singh TP; Ahmad F
Cell Mol Life Sci; 2009 Feb; 66(3):447-59. PubMed ID: 18854942
[TBL] [Abstract][Full Text] [Related]
59. Cancer immunology. Identifying the infiltrators.
Gomez Perdiguero E; Geissmann F
Science; 2014 May; 344(6186):801-2. PubMed ID: 24855239
[No Abstract] [Full Text] [Related]
60. Cholesterol regulation of PIP(2): why cell type is so important.
Taglieri DM; Delfín DA; Monasky MM
Front Physiol; 2012; 3():492. PubMed ID: 23316171
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
